Relapsed or Refractory Lymphoma
5 clinical trials · Condition
◉ Watch Relapsed or Refractory Lymphoma
| Record | Firm | Date |
|---|---|---|
| HMPL-523 Food Effect and Proton Pump Inhibitor Study (NCT05571787) | Hutchmed | 2022-07-13 |
| HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI (NCT05602597) | Hutchmed | 2022-06-01 |
Track Relapsed or Refractory Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.